A4 Test I agree with a lot of your comments Nrgzr, but I don't think we will ever see the contract with JSW. The letter of intent and many partnership opportunities presented were a smoke screen. Makes sense that a Pharma company would want complete control over all of Amorfix's Alzheimer's technology. Think about the competitve advantage of the A4 test with a Pharma company that can test promising new cures for Alzheimer's from other companies, in Animal models, a year before conventional methods and have that propriety information.